Streetbeat News

Equity Actions

AAON

AAON has announced a $25 million increase in its share repurchase authorization, bringing the total to $50 million. The repurchases will be conducted under a pre-arranged plan following Rule 10b5-1 guidelines, with the timing and amount depending on market conditions.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 8:36 pm

BAYRY

BAYZF

Bayer AG, under new CEO Bill Anderson, has decided to postpone any plans to split the company into separate units for the next three years, focusing instead on addressing current challenges, boosting performance, and creating strategic flexibility. The company is evaluating the potential separation of its Consumer Health or Crop Science divisions but has ruled out a three-way split. Bayer aims to focus on its pharmaceuticals pipeline, litigation, debt reduction, and implementing a new operating model to improve performance, expecting to cut annual costs by €2 billion from 2026. Fiscal year 2023 saw a decline in Crop Science sales, stable Pharmaceuticals sales, and an increase in Consumer Health sales. Bayer forecasts fiscal year 2024 sales between €47 billion to €49 billion, with adjusted EBITDA of €10.7 billion to €11.3 billion, and core earnings per share of €5.10 to €5.50.

Portfolio Pulse from Vandana Singh

March 05, 2024 | 8:25 pm

TWLO

Twilio shares are trading lower due to overall weakness in tech stocks, despite the company announcing a $2 billion share repurchase authorization and affirming its Q1 guidance. Twilio also provided guidance for FY24 and FY25.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 7:46 pm

AAPL

QQQ

SPY

TLT

TSLA

Wall Street experienced volatility with major indices down, led by a plunge in mega-cap tech stocks. Tesla and Apple saw significant losses, influenced by a report of declining iPhone sales in China. Bitcoin's value dropped after reaching a record high, while Treasury yields fell, hinting at potential Federal Reserve rate cuts. The iShares 20+ Year Treasury Bond ETF saw gains. Various stocks and ETFs moved based on earnings reports, analyst notes, and capital raising plans.

Portfolio Pulse from Piero Cingari

March 05, 2024 | 7:01 pm

SMRT

SmartRent (NYSE:SMRT) shares fell after reporting Q4 earnings below expectations and providing weak revenue guidance for Q1 and FY24. Despite a 49% Y/Y revenue increase to $60.25 million and a positive adjusted EBITDA of $0.7 million, EPS of $(0.02) missed estimates. The company also announced a $50 million stock repurchase program but projected lower-than-expected revenue for the upcoming periods.

Portfolio Pulse from Lekha Gupta

March 05, 2024 | 6:07 pm

SGRY

Surgery Partners (NASDAQ:SGRY) has been evaluated by 4 analysts over the last three months, showing a diverse range of opinions. Recent ratings indicate a shift towards a more bullish outlook, with an average 12-month price target of $44.25, reflecting a 2.91% increase from the previous target of $43.00. The company's financial overview reveals a solid revenue growth rate of 4.0% as of December 31, 2023, an impressive net margin, and strong financial health indicators such as ROE and ROA. Surgery Partners operates in healthcare services, focusing on outpatient surgical and ancillary care.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 6:01 pm

AXP

COIN

HOOD

PYPL

SOFI

STNE

TOST

WFC

Today's whale activity in the Financials sector highlighted significant options trading across various stocks, indicating potential trading opportunities. Notable bearish sentiment was observed in AXP, SOFI, SQ, and PYPL call options, while WFC, STNE, COIN, and HOOD call options showed bullish sentiment. TOST call options were bearish, and AX put options were bullish. These activities suggest investors' expectations on the future price movements of these stocks.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 5:35 pm

AKRO

Akero Therapeutics announced a $300 million public offering, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 5:25 pm

LGCL

Lucas GC (LGCL) shares opened for trading at $5 per share, higher than the IPO price of $4 per share.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 4:11 pm

LGCL

Lucas GC's IPO was priced at $4 per share, but indications suggest it could open at $4.75 per share.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 4:09 pm